BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Lattice Biologics Ltd. Announces Change in Director and Change in Status of Chief Operating Officer

  Board of Director Mario Stifano resigned his position effective December 12, 2017, due to conflicting time priorities.

  December 22, 2017

   · 

  2 min read
• 

  FDA

  Novartis’ Tasigna Wins FDA Nod for First and Only CML Therapy With Treatment-Free Remission Data in Its Label

  Novartis announced today that the FDA approved the inclusion of Treatment-free Remission data in the Tasigna U.S. product label.

  December 22, 2017

   · 

  13 min read
• Helix BioPharma Corp. Closes Private Placement

  Helix BioPharma Corp. announced it has closed a private placement financing for gross proceeds of CAD750,600.

  December 22, 2017

   · 

  3 min read
• Business

  GBT Appoints Wendy L. Yarno to Board of Directors

  Ms. Yarno has more than 25 years of experience in the biopharmaceutical industry, including serving as chief marketing officer at Merck.

  December 22, 2017

   · 

  6 min read
• Business

  THERADIAG Signs a Partnership Agreement for Monitoring of Remicade

  Theradiag today announced that it had signed a partnership with MSD France to supply its LISA TRACKER kits for the monitoring of Remicade.

  December 22, 2017

   · 

  2 min read
• BioCapital

  Metavivor Announces 2017 Grant Awards for Metastatic Cancer Research

  METAvivor Research and Support, a non-profit organization dedicated to funding research for Stage IV MBC, announces twelve grant awards totaling $1,650,000.

  December 22, 2017

   · 

  4 min read
• Drug Development

  Glycotope Initiates Phase Ib Trial of Combination of Proprietary Anti-Tumor Antibodies

  Glycotope today announces it has enrolled the first patient in its international GATTO study which combines two of the Company’s immuno-oncology assets derived from its world-leading glycobiology expertise.

  December 22, 2017

   · 

  4 min read
• BioMidwest

  Local and National Organizations Benefit From AIT Bioscience CEO’s Leadership

  The Vanguard Forum for Healthcare Leaders invited AIT Bioscience CEO Terri Pascarelli to serve as a faculty member at its November 2017 event in New York City, NY.

  December 22, 2017

   · 

  2 min read
• BioMidwest

  AIT Bioscience Recognized with Awards at Recent WRIB

  WRIB (Workshop for Recent Issues in Bioanalysis) is an annual gathering of bioanalytical scientists from across the pharmaceutical industry spectrum.

  December 22, 2017

   · 

  2 min read
• 

  BioMidwest

  Zimmer Biomet Shows Off Pilot Data for nStride Knee Injection

  The pilot study enrolled 46 patients with unilateral, mild-to-moderate, symptomatic knee OA pain from the four trial sites across Europe.

  December 22, 2017

   · 

  7 min read